July 6, 2020 – Bayer AG, Merck KGaA, Novartis, Pfizer and Vertex are joining other major advertisers in support of a July Facebook ad boycott (#StopHateForProfit), a campaign started by six civil rights organizations – the Anti-Defamation League, NAACP, Sleeping Giants, Color Of Change, Free Press and Common Sense – that calls on corporate advertisers to […]
Read more
Dec. 9, 2019 – The Office of Prescription Drug Promotion’s (OPDP’s) proposed study of the increasingly-common direct-to-consumer (DTC) television advertising for oncology drugs seeks to examine how consumers parse the information they are receiving, but commenters on the proposal argue that some of the study’s parameters should be changed before moving forward. The proposed OPDP […]
Read more
Sept. 5, 2017 – An FDA-proposed study to determine whether healthcare professionals (HCPs) and consumers can utilize disclosures to correctly frame efficacy claims in prescription drug promotion raises First Amendment concerns about communication and requires fixes to the study construct, according to August comments on the June 14 proposal. “Disclosure is an important topic that […]
Read more